Original Article

Application of Different Continuous Renal Replacement Therapy Hemofilter in Patients with Septic Shock Complicated with Acute Renal Injury

Abstract

Background: We aimed to compare the clinical effects of continuous renal replacement therapy (CRRT) with different hemofilters in patients with septic shock and acute kidney injury (AKI).

Methods: Thirty patients with septic shock complicated with AKI admitted to The Fourth Affiliated Hospital of Anhui Medical University from 2018-2020 were selected and divided into the control and observation groups. The control group was treated with CRRT using the conventional ST-100 hemofilter. The observation group was treated with CRRT using the oXiris hemofilter for 48 hours, followed by CRRT with the conventional ST-100 hemofilter. Infection indexes, sepsis-related organ failure assessment (SOFA), changes in corresponding organ function indexes, duration of each treatment, and death were compared between the two groups during CRRT.

Results: The white blood cells (WBC) count, high-sensitivity C-reactive protein (hs-CRP), and procalcitonin (PCT) levels were significantly decreased in the oXiris group 48 hours after CRRT (P= 0.048, 0.036, 0.031, respectively). After 48 hours of CRRT, SOFA score, serum lactic acid, and norepinephrine dose in the oXiris group were significantly lower than those in the control group (P= 0.039, 0.002, 0.021, respectively). The use time of vasoactive drugs and the treatment time of CRRT in the oXiris group was significantly shortened (P= 0.031 and 0.029, respectively). However, there were no significant differences in mechanical ventilation duration, intensive care unit (ICU) hospitalization time, total hospitalization time, ICU mortality, and in-hospital mortality.

Conclusion: For patients with septic shock complicated by AKI, CRRT treatment with the oXiris hemofilter could effectively clear inflammatory cytokine levels and quickly correct hemodynamic disorders, thus accelerating the recovery of organ function.

1. Singer M, Deutschman CS, Seymour CW, et al (2016). The Third International Con-sensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315: 801-10.
2. Font MD, Thyagarajan B, Khanna AK, et al (2020). Sepsis and Septic Shock - Basics of diagnosis, pathophysiology and clinical decision making. Med Clin North Am, 104: 573-85.
3. Romagnoli S, Ricci Z, Ronco C (2018). CRRT for sepsis-induced acute kidney in-jury. Curr Opin Crit Care, 24: 483-92.
4. Marshall JC (2010). Endotoxin in the path-ogenesis of sepsis. Contrib Nephrol, 167: 1-13.
5. Broman ME, Hansson F, Vincent JL, et al (2019). Endotoxin and cytokine reducing properties of the oXiris membrane in pa-tients with septic shock: A randomized crossover double-blind study. PLoS One, 14: e0220444.
6. Broman ME, Bodelsson M (2019). Analysis of Endotoxin Adsorption in Two Swe-dish Patients with Septic Shock. Blood Pu-rif, 47 Suppl 3: 1-3.
7. Shum HP, Chan KC, Kwan MC, et al (2013). Application of endotoxin and cy-tokine adsorption haemofilter in septic acute kidney injury due to Gram-negative bacterial infection. Hong Kong Med J, 19: 491-7.
8. Thomas ME, Blaine C, Dawnay A, et al (2015). The definition of acute kidney in-jury and its use in practice. Kidney Int, 87: 62-73.
9. Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA (2019). Acute kid-ney injury from sepsis: current concepts, epidemiology, pathophysiology, preven-tion and treatment. Kidney Int, 96: 1083-99.
10. Wang KF, Xie SL, Xiao K, et al (2018). Bi-omarkers of Sepsis-Induced Acute Kid-ney Injury. Biomed Res Int, 2018: 6937947.
11. Gómez H, Kellum JA (2016). Sepsis-induced acute kidney injury. Curr Opin Crit Care, 22: 546-53.
12. Zarbock A, Gomez H, Kellum JA (2014). Sepsis-induced acute kidney injury revisit-ed: pathophysiology, prevention and fu-ture therapies. Curr Opin Crit Care, 20: 588-95.
13. Dai T, Cao S, Yang X (2016). Zhonghua w Comparison of clinical efficacy between continuous renal replacement therapy and intermittent haemodialysis for the treat-ment of sepsis-induced acute kidney inju-ry. Ei Zhong Bing Ji Jiu Yi Xue, 28: 277-80.
14. Tian H, Sun T, Hao D, et al (2014). The op-timal timing of continuous renal replace-ment therapy for patients with sepsis-induced acute kidney injury. Int Urol Neph-rol, 46: 2009-14.
15. Hattori N, Oda S (2016). Cytokine-adsorbing hemofilter:old but new mo-dality for septic acute kidney injury. Ren Repl Ther, 2: 41.
16. Malard B, Lambert C, Kellum JA (2018). In vitro comparison of the adsorption of inflammatory mediators by blood purifi-cation devices. Intensive Care Med Exp, 6: 12.
17. Turani F, Barchetta R, Falco M, et al (2019). Continuous Renal Replacement Therapy with the Adsorbing Filter oXiris in Septic Patients: A Case Series. Blood Purif, 47 Suppl 3: 1-5.
18. Tan HK, Kaushik M, Tan CW, et al (2019). Augmented Adsorptive Blood Purifica-tion during Continuous Veno-Venous Haemodiafiltration in a Severe Septic, Acute Kidney Injury Patient: Use of oXiris®: A Single Centre Case Report. Blood Purif, 47 Suppl 3: 1-6.
19. Schwindenhammer V, Girardot T, Chaulier K, et al (2019). oXiris® Use in Septic Shock: Experience of Two French Cen-tres. Blood Purif, 47 Suppl 3: 1-7.
20. Ma J, Xia P, Zhou Y, et al (2020). Potential effect of blood purification therapy in re-ducing cytokine storm as a late complica-tion of critically ill COVID-19. Clinical im-munology (Orlando, Fla), 214: 108408.
Files
IssueVol 51 No 10 (2022) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijph.v51i10.10990
Keywords
Continuous renal replacement therapy Septic shock Acute kidney injury
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Liu S, Cao Q, Sun R, Wang N. Application of Different Continuous Renal Replacement Therapy Hemofilter in Patients with Septic Shock Complicated with Acute Renal Injury. Iran J Public Health. 2022;51(10):2317-2324.